printer version
Presentation Schedule
View the Complete Presentation Schedule
| Wednesday, November 19, 2003 |
| 9:50 AM | 204A |
CEPTYR, Inc. |
Metabolic |
| 9:50 AM | 204C |
GlycoMimetics, Inc. |
Inflammation |
| 10:00 AM | 204A |
Aureon Biosciences Corporation |
Cancer |
| 10:00 AM | 204C |
Acceptys, Inc. |
Antibodies |
| 10:10 AM | 204A |
EluSys Therapeutics, Inc. |
Cancer |
| 10:10 AM | 204C |
Bionaut Pharmaceuticals, Inc. |
Enabling Technology |
| 10:20 AM | 204A |
Neuronyx, Inc. |
Gene/Cell Therapy |
| 10:20 AM | 204C |
Revivicor, Inc. |
Transplant |
| 10:30 AM | 204A |
Nucleonics, Inc. |
Infectious Disease |
| 10:30 AM | 204C |
MaxCyte, Inc. |
Gene/Cell Therapy |
| 10:40 AM | 204A |
GliaMed, Inc. |
CNS/Neurology |
| 10:40 AM | 204C |
Acuity Pharmaceuticals |
Enabling Technologies |
| 10:50 AM | 204A |
PhageTech Inc. |
Infectious Disease |
| 10:50 AM | 204C |
Glyconix Corp. |
Enabling Technology |
| 11:00 AM | 204A |
Biosyn, Inc. |
Infectious Diseases |
| 11:00 AM | 204C |
APT Therapeutics, Inc. |
Drug Discovery |
| 11:10 AM | 204A |
MacroGenics, Inc. |
Antibodies |
| 11:10 AM | 204C |
Chaperone Technologies, Inc. |
Infectious Diseases |
| 11:20 AM | 204A |
RenalTech International, LLC |
Renal |
| 11:20 AM | 204C |
Cytochroma Inc. |
Drug Discovery |
| 11:30 AM | 204A |
Protein Forest, Inc. |
Proteomics |
| 11:30 AM | 204C |
Protez Pharmaceuticals Inc. |
Infectious Diseases |
|